Virios Therapeutics(VIRI) - 2025 Q3 - Quarterly Report

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 (State or other jurisdiction of incorporation or organization) Delaware 85-4314201 (I.R.S. Employer Identification Number) 44 Milton Avenue Alpharetta, GA 30009 (Address of Principal Executive Offices) (866) 620-8655 (Registrant's telephone number) or ☐ TRANSIT ...